TP53 and hepatoblastoma: Indeed, we have previously shown that in hepatoblastoma HepG2 cells, which carry mutated CTNNB1 and wild-type TP53, constant activation of the TP53/miR-145-5p signaling selects cells with high miR-483-3p expression that are resistant to apoptosis.